spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  EMG 

 HSMN NewsFeed - 2 Apr 2026
Zeto Announces FDA 510(k) Clearance of Zeto New Wave(TM), Advancing Efficiency in Outpatient EEG
Devices FDA
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 8 Dec 2023
AMETEK Completes Acquisition of Paragon Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 24 Jun 2020
Senzime Expands US Sales Team and Signs Additional Distribution Agreements
Devices Monitoring Distribution
 HSMN NewsFeed - 26 May 2020
Emgality(R) Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Dec 2019
Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality(R) (galcanezumab-gnlm)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Aug 2019
Lilly Announces Positive Results for Emgality(R) (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jul 2019
AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality(R) (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2019
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality(R) (galcanezumab-gnlm) in Episodic Cluster Headache
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Sep 2018
Lilly Receives Positive CHMP Opinion for Emgality(TM) (galcanezumab) for the Prophylaxis of Migraine in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 27 Jun 2017
DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 15 Jun 2017
Magstim Group, Inc. Appoints Lothar Krinke as New CEO
Devices Neurology Personnel
 HSMN NewsFeed - 10 Mar 2017
Cadwell Launches Arc Synopsis(TM) Trends and Seizure Detection
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Feb 2017
CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Feb 2016
Protagonist Therapeutics Names Thomas P. O'Neil Chief Financial Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 10 Sep 2015
Rosa Griffin Joins Intronix Technologies as Sales and Marketing Manager
Devices Personnel
 HSMN NewsFeed - 16 Oct 2014
Natus Medical Announces First of Kind Vista Ultrasound System
Devices Product Launch
 HSMN NewsFeed - 21 Jul 2014
Zynex Announces Brian Alleman as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 25 Jun 2014
Zynex Appoints Director of Business Development
Devices Personnel
 HSMN NewsFeed - 5 Mar 2014
Intronix Technologies Announces New Canadian Distributor for Myoguide(TM), the Latest Guided Injection System Innovation
Devices Distribution
 HSMN NewsFeed - 7 Jan 2014
Zynex Appoints Vice President of Sales for NeuroDiagnostics Division
Devices Neurology Personnel
 HSMN NewsFeed - 15 Aug 2013
Intronix Technologies Attending AAPM&R Event to Share Myoguide(TM), Latest Guided Injection System Breakthrough
Devices Drug Delivery Distribution
 HSMN NewsFeed - 30 Apr 2013
Kevin M. Smith Appointed to Zynex Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 14 Jan 2013
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 14 Nov 2012
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
Regenerative Medicine Neurology
 HSMN NewsFeed - 30 Aug 2012
Zynex Receives FDA 510(k) Clearance for InWave Medical Device
Devices Urology FDA
 HSMN NewsFeed - 22 May 2012
Talon Therapeutics Appoints Head of Commercial Operations and Planning
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 19 Apr 2012
Intronix Technologies Corp. Hires Bruce Ross as VP of Sales & Marketing
Devices Personnel
 HSMN NewsFeed - 12 Mar 2012
Zynex Acquires NeuroDyne Medical, Corp.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2011
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
Devices Neurology FDA
 HSMN NewsFeed - 31 Aug 2011
Zynex Appoints Vice President of Reimbursement and Billing
Devices Personnel
 HSMN NewsFeed - 13 May 2011
SRS Medical Introduces System for Complete Urodynamics(TM)
Devices Urology
 HSMN NewsFeed - 31 Mar 2011
iTech Medical Appoints Warren G. Baker as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 22 Feb 2011
iTech Medical Appoints Warren G. Baker as President, COO and Director
Devices Personnel
 HSMN NewsFeed - 29 Dec 2010
Zynex Strengthens Management Team; Adds Regulatory Compliance Expert
Devices Personnel
 HSMN NewsFeed - 30 Nov 2010
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
Devices Neurology Personnel
 HSMN NewsFeed - 10 Dec 2009
FDA clears Nexstim's Navigated Brain Stimulation for non-invasive cortical mapping prior to neurosurgery
Devices Neurosurgery FDA
 HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Sep 2009
Natus Medical to Acquire Alpine Biomed
Devices Monitoring Neurology Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2009
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Mar 2009
NeuroMetrix to Reorganize US Sales Operations
Devices Personnel
 HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Dec 2008
Nihon Kohden Announces Acquisition of Neurotronics Inc.
Devices Neurology Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2008
Nihon Kohden Expands Integration of Masimo SET(R) Pulse Oximetry Technology Worldwide
Devices Monitoring Licensing
 HSMN NewsFeed - 2 Oct 2008
NeuroMetrix Receives FDA 510(k) Clearance for UNIVERSAL(TM) Electrodes used in the Performance of Nerve Conduction Studies
Devices Neurology FDA
 HSMN NewsFeed - 15 Sep 2008
Biovitrum to Acquire Kepivance(R) and Stemgen(R) and Exclusively License Kineret(R) from Amgen
Biopharmaceuticals Acquisitions Licensing
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2007
Natus Medical to Acquire Excel-Tech Ltd.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2007
Finland's Nexstim Completes EUR 8 Million Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 1 Aug 2007
Alpine Biomed Corp. Announces Acquisition of Medtronic's Neurodiagnostic Product Line
Devices Neurology Acquisitions
 HSMN NewsFeed - 26 Jul 2007
Medtronic Announces Agreement with Spinal Neuromonitoring Innovator
Devices Monitoring Distribution Neurosurgery
 HSMN NewsFeed - 12 Jun 2007
LinkMed: SACS Medical is Granted FDA Clearance
Devices Monitoring FDA
 HSMN NewsFeed - 1 May 2007
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
Devices Neurology Monitoring
 HSMN NewsFeed - 30 Apr 2007
Baxa Corporation Announces Enteral Syringes Now on Contract With AmeriNet, MedAssets, Novation and Premier Group Purchasing Organizations
Devices Group Purchasing
 HSMN NewsFeed - 10 Apr 2007
Hospitals, Healthcare Providers to Save with Premier Neurological Equipment and Related Products Agreements
Devices Group Purchasing
 HSMN NewsFeed - 14 Feb 2007
Clinical Data Supporting Development of ChemGenex's Ceflatonin(R) in Imatinib-Resistant CML Published in Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Nov 2006
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
Biopharmaceuticals Oncology FDA
Return to NewsFeed  

 Additional items found! 33

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 33 additional stories matching:
EMG
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!